UKCPA: Make CVD prevention your key priority

Learning

UKCPA: Make CVD prevention your key priority

In Learning

There are plenty of opportunities for pharmacists to improve the cardiovascular profile of their local area, says Paul Wright, an NHS lead cardiac pharmacist

Nationally, there is a big focus on the prevention of cardiovascular disease (CVD), with the Department of Health and Social Care making this a key priority. There are around 7 million people living with CVD in England, which contributes to 25 per cent of deaths each year. There is also a significant financial implication, with just under £7bn being spent by the NHS each year as a consequence of CVD.

Stumbling block

One of the stumbling blocks to preventing CVD is appropriate identification of those at risk.

If a person doesn’t know they have CVD, appropriate primary prevention cannot be initiated. By way of an example, it is suggested that there are 5 million adults with undiagnosed hypertension, and that 30 per cent of patients with atrial fibrillation and 85 per cent of those with familial hypercholesterolaemia are undiagnosed.

Helpful tools

Clearly, there is scope for improvement and a number of tools and services to facilitate this are available including:

  • NHS Health Checks, if aged between 40 and 74 years
  • Asking patients if they know their recent blood pressure readings and offering a blood pressure check if they are unsure
  • Asking patients if they have recently had their cholesterol checked and offering testing where appropriate
  • Using QRISK tool to assess CVD risk.

Strategies

Following identification of CVD, appropriate treatment and prevention strategies need to be initiated. Again, local and national data highlight significant opportunities to improve primary prevention. There are 1.6 million patients recorded on GP registers as having hypertension but not being treated to targets of less than 150/90mmHg, with far more not attaining targets of less than 140/90mmHg.

Despite strong evidence for anticoagulation reducing the incidence of stroke in those with AF, just under one in five patients on GP registers with AF and deemed high risk do not receive anticoagulation. It is also estimated that half the adult population with an estimated CVD risk >20 per cent are treated with a statin – the figure for those with a CVD risk >10 per cent being significantly less.

Lifestyle advice

With a quarter of men and women obese and many more overweight, a third of men and over half of women underactive and over 65 per cent consuming excess salt and saturated fat, there is plenty of opportunity to make significant lifestyle interventions and offer useful advice.

For more infomation about the UKCPA access ukclinicalpharmacy.org

This column is produced in association with the UKCPA. The views expressed are those of the author and are not necessarily those of either Pharmacy Magazine or the UKCPA.

Record my learning outcomes

Learning

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Learning

Viatris: Pharmacist Support

Enhance therapy area knowledge in your pharmacy and help staff learn new patient engagement techniques with learning resources from Viatris designed to boost your pharmacy business.

bookmark_icon_off
Learning

Learning update: Cracking patients' skin conditions

While the healthcare system’s focus is on tackling the coronavirus pandemic, patients must continue to deal with long-term medical conditions such as chronic skin disorders.

6 Min Article

bookmark_icon_off
Learning

Applications open for foundation pharmacist training

CPPE has opened applications for the newest intake of pharmacists on its foundation pharmacist training pathway. Limited places are available.

1 Min Article

bookmark_icon_off
Learning

UKCPA viewpoint: Tofacitinib raises risk of PE

There is an increased risk of pulmonary embolism in patients receiving tofacitinib 10mg twice daily.

1 Min Article

bookmark_icon_off
Learning

UKCPA: Are all coxibs made equal?

It's over 10 years since the MHRA advised that the decision to prescribe a NSAID should be based on an assessment of a patient’s individual risk factors.

1 Min Article

bookmark_icon_off
Learning

CPPE: New e-learning on atrial fibrillation

AF has been identified as a condition where opportunistic screening could be beneficial. Community pharmacy is well placed to support this screening.

1 Min Article

bookmark_icon_off
Learning

UKCPA: Identifying anaemia

Pharmacist are well placed to identify the signs and symptoms of anaemia and advise on treatment, says a lead pre-operative pharmacist.

1 Min Article

bookmark_icon_off
Learning

UKCPA: New focal point on asthma

The focal point programme has been developed to provide clinically focused sessions that present information and activities relevant for pharmacy professionals.

1 Min Article

bookmark_icon_off
Learning

UKCPA: Make CVD prevention your key priority

There are plenty of opportunities for pharmacists to improve the cardiovascular profile of their local area.

1 Min Article

bookmark_icon_off
Learning

CPPE: New places on Leading for Change programme

The programme aims to help experienced pharmacy professionals reflect on and develop their leadership style.

1 Min Article

bookmark_icon_off
Learning

Scenario: Kidney dialysis

Pharmacist Paeveen on the options available when a patient waith kidney disease love to travel

2 Min Article

bookmark_icon_off
Learning

CPPE: New gateway page on DMIRS

CPPE is introducing learning resources for the Digital Minor Illness Referral Service (DMIRS)

1 Min Article

bookmark_icon_off
Learning

UKCPA: Initiatives to tackle penicillin allergy

Researchers in the NHS are looking at allergies, in particular penicillin allergy, says pharmacist Yogini Jani.

1 Min Article

bookmark_icon_off
Learning

CPPE: Tech programme is now national

CPPE’s accuracy checking pharmacy technician programme is now available to all pharmacy technicians.

1 Min Article

bookmark_icon_off
Learning

UKCPA: What is autonomic dysreflexia?

Autonomic dysreflexia (AD) deserves a wider level of understanding among pharmacists.

1 Min Article

Recommended Learning

bookmark icon off
Sponsored education

OTC Omeprazole tablets 20mg: an opportunity for pharmacy

This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.

10 Min Module

Sponsored education

Acute diarrhoea: effective symptom management

This module busts the myths surrounding diarrhoea treatments and explores the products available OTC so you can recommend the right treatment.

10 Min Module

bookmark icon off
Sponsored education

Supporting daily digestive health

Learn about the crucial role of gut bacteria and how a healthy microbiome can support daily digestive health

2 Min Module

bookmark icon off
Sponsored education

Managing hay fever: help meet your customers' needs

This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms

15 Min Module

Sponsored education

Advising on very dry and eczema-prone skin

This video will guide you through a consultation with Michelle, a customer with very dry skin, and help you recommend suitable products to help

2 Min Module

bookmark icon off
Sponsored education

Sore throats and antibiotic resistance

This module will help you to understand and educate customers about the risks of antibiotic resistance, and recommend products to help them effectively manage their sore throat symptoms.

 

10 Min Module